Sanofi Buys Australia’s Primary Health For $544 Million
This article was originally published in PharmAsia News
Sanofi-Aventis is buying Australia's Primary Health Care, the nation's largest distributor of vitamin supplements, for $544 million. In reaching agreement with Primary, Sanofi bested Merck KgaA of Germany. In a separate deal, Primary is about to cease taking bids for its pharmacy business, expected to garner $487.2 million, with Zuelig Pharma of Switzerland considered a potential bidder. Primary has been selling off units after taking over Symbion Health, a maker of medical-testing equipment, earlier this year. (Click here for more
You may also be interested in...
From efficacy endpoints to patient warehousing, US FDA advisors weigh in on vaccine development and regulatory review.
Several years ago, heart device giant Edwards Lifesciences realized it needed a new CAPA framework that shifts corrective and preventive action from a one-size-fits-all method to a more nuanced approach. See what Dan Buehner, director of quality engineering at Edwards Lifesciences, said about it here.
FDA's recommendation that COVID-19 vaccine sponsors conduct two months of median follow-up to support an emergency use authorization may not be long enough, some experts say in what can be viewed as validation for agency's position in battle with White House.